Why Your Patients' Believing Hydroxychloroquine and Chloroquine Are 90% Effective for COVID-19 Is 100% Dangerous.
Identifieur interne : 001424 ( Main/Corpus ); précédent : 001423; suivant : 001425Why Your Patients' Believing Hydroxychloroquine and Chloroquine Are 90% Effective for COVID-19 Is 100% Dangerous.
Auteurs : C Michael White ; Adrian V. HernandezSource :
- Journal of clinical pharmacology [ 1552-4604 ] ; 2020.
English descriptors
- KwdEn :
- Antimalarials (adverse effects), Antimalarials (therapeutic use), COVID-19 (MeSH), Chloroquine (adverse effects), Chloroquine (therapeutic use), Coronavirus Infections (drug therapy), Coronavirus Infections (mortality), Culture (MeSH), Endpoint Determination (MeSH), Humans (MeSH), Hydroxychloroquine (adverse effects), Hydroxychloroquine (therapeutic use), Pandemics (MeSH), Patient Education as Topic (MeSH), Pneumonia, Viral (drug therapy), Pneumonia, Viral (mortality), Randomized Controlled Trials as Topic (MeSH).
- MESH :
- chemical , adverse effects : Antimalarials, Chloroquine, Hydroxychloroquine.
- chemical , therapeutic use : Antimalarials, Chloroquine, Hydroxychloroquine.
- drug therapy : Coronavirus Infections, Pneumonia, Viral.
- mortality : Coronavirus Infections, Pneumonia, Viral.
- COVID-19, Culture, Endpoint Determination, Humans, Pandemics, Patient Education as Topic, Randomized Controlled Trials as Topic.
DOI: 10.1002/jcph.1687
PubMed: 32530493
PubMed Central: PMC7307015
Links to Exploration step
pubmed:32530493Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Why Your Patients' Believing Hydroxychloroquine and Chloroquine Are 90% Effective for COVID-19 Is 100% Dangerous.</title><author><name sortKey="White, C Michael" sort="White, C Michael" uniqKey="White C" first="C Michael" last="White">C Michael White</name><affiliation><nlm:affiliation>University of Connecticut School of Pharmacy, Storrs, Connecticut, USA.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Hartford Hospital Department of Research Administration, Hartford, Connecticut, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Hernandez, Adrian V" sort="Hernandez, Adrian V" uniqKey="Hernandez A" first="Adrian V" last="Hernandez">Adrian V. Hernandez</name><affiliation><nlm:affiliation>University of Connecticut School of Pharmacy, Storrs, Connecticut, USA.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Hartford Hospital Department of Research Administration, Hartford, Connecticut, USA.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32530493</idno><idno type="pmid">32530493</idno><idno type="doi">10.1002/jcph.1687</idno><idno type="pmc">PMC7307015</idno><idno type="wicri:Area/Main/Corpus">001424</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001424</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Why Your Patients' Believing Hydroxychloroquine and Chloroquine Are 90% Effective for COVID-19 Is 100% Dangerous.</title><author><name sortKey="White, C Michael" sort="White, C Michael" uniqKey="White C" first="C Michael" last="White">C Michael White</name><affiliation><nlm:affiliation>University of Connecticut School of Pharmacy, Storrs, Connecticut, USA.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Hartford Hospital Department of Research Administration, Hartford, Connecticut, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Hernandez, Adrian V" sort="Hernandez, Adrian V" uniqKey="Hernandez A" first="Adrian V" last="Hernandez">Adrian V. Hernandez</name><affiliation><nlm:affiliation>University of Connecticut School of Pharmacy, Storrs, Connecticut, USA.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Hartford Hospital Department of Research Administration, Hartford, Connecticut, USA.</nlm:affiliation></affiliation></author></analytic><series><title level="j">Journal of clinical pharmacology</title><idno type="eISSN">1552-4604</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antimalarials (adverse effects)</term><term>Antimalarials (therapeutic use)</term><term>COVID-19 (MeSH)</term><term>Chloroquine (adverse effects)</term><term>Chloroquine (therapeutic use)</term><term>Coronavirus Infections (drug therapy)</term><term>Coronavirus Infections (mortality)</term><term>Culture (MeSH)</term><term>Endpoint Determination (MeSH)</term><term>Humans (MeSH)</term><term>Hydroxychloroquine (adverse effects)</term><term>Hydroxychloroquine (therapeutic use)</term><term>Pandemics (MeSH)</term><term>Patient Education as Topic (MeSH)</term><term>Pneumonia, Viral (drug therapy)</term><term>Pneumonia, Viral (mortality)</term><term>Randomized Controlled Trials as Topic (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antimalarials</term><term>Chloroquine</term><term>Hydroxychloroquine</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antimalarials</term><term>Chloroquine</term><term>Hydroxychloroquine</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" xml:lang="en"><term>COVID-19</term><term>Culture</term><term>Endpoint Determination</term><term>Humans</term><term>Pandemics</term><term>Patient Education as Topic</term><term>Randomized Controlled Trials as Topic</term></keywords></textClass></profileDesc></teiHeader></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32530493</PMID><DateCompleted><Year>2020</Year><Month>07</Month><Day>23</Day></DateCompleted><DateRevised><Year>2020</Year><Month>12</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1552-4604</ISSN><JournalIssue CitedMedium="Internet"><Volume>60</Volume><Issue>8</Issue><PubDate><Year>2020</Year><Month>08</Month></PubDate></JournalIssue><Title>Journal of clinical pharmacology</Title><ISOAbbreviation>J Clin Pharmacol</ISOAbbreviation></Journal><ArticleTitle>Why Your Patients' Believing Hydroxychloroquine and Chloroquine Are 90% Effective for COVID-19 Is 100% Dangerous.</ArticleTitle><Pagination><MedlinePgn>949-953</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/jcph.1687</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>White</LastName><ForeName>C Michael</ForeName><Initials>CM</Initials><Identifier Source="ORCID">0000-0002-9367-4893</Identifier><AffiliationInfo><Affiliation>University of Connecticut School of Pharmacy, Storrs, Connecticut, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hartford Hospital Department of Research Administration, Hartford, Connecticut, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hernandez</LastName><ForeName>Adrian V</ForeName><Initials>AV</Initials><AffiliationInfo><Affiliation>University of Connecticut School of Pharmacy, Storrs, Connecticut, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hartford Hospital Department of Research Administration, Hartford, Connecticut, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>07</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Clin Pharmacol</MedlineTA><NlmUniqueID>0366372</NlmUniqueID><ISSNLinking>0091-2700</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000962">Antimalarials</NameOfSubstance></Chemical><Chemical><RegistryNumber>4QWG6N8QKH</RegistryNumber><NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance></Chemical><Chemical><RegistryNumber>886U3H6UFF</RegistryNumber><NameOfSubstance UI="D002738">Chloroquine</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Protocol" UI="C000705127">COVID-19 drug treatment</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000962" MajorTopicYN="N">Antimalarials</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002738" MajorTopicYN="N">Chloroquine</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003469" MajorTopicYN="N">Culture</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D023381" MajorTopicYN="N">Endpoint Determination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006886" MajorTopicYN="N">Hydroxychloroquine</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010353" MajorTopicYN="Y">Patient Education as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">COVID-19</Keyword><Keyword MajorTopicYN="Y">chloroquine</Keyword><Keyword MajorTopicYN="Y">hydroxychloroquine</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>05</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>06</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>6</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>7</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>6</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32530493</ArticleId><ArticleId IdType="doi">10.1002/jcph.1687</ArticleId><ArticleId IdType="pmc">PMC7307015</ArticleId></ArticleIdList><ReferenceList><Title>References</Title><Reference><Citation>Mora E. Doctors: Over ‘90% Chance’ Hydroxychloroquine Can Help Coronavirus Patients. 2020. https://www.breitbart.com/politics/2020/04/29/doctors-over-90-chance-hydroxychloroquine-can-help-coronavirus-patients/. Accessed May 24, 2020.</Citation></Reference><Reference><Citation>Darby L. Why Did Fox News's Laura Ingraham Relentlessly Push Hydroxychloroquine? GQ Magazine. 2020. https://www.gq.com/story/ingraham-still-on-hydroxychloroquine-train. Accessed May 24, 2020.</Citation></Reference><Reference><Citation>AAPS Online. Hydroxychloroquine Has about 90 Percent Chance of Helping COVID-19 Patients. 2020. https://aapsonline.org/hcq-90-percent-chance Accessed May 24, 2020.</Citation></Reference><Reference><Citation>Linton C. Trump says he is taking hydroxychloroquine. CBS News; 2020. https://www.cbsnews.com/news/hydroxychloroquine-donald-trump-taking-drug-covid-19-prevention/.</Citation></Reference><Reference><Citation>Vaduganathan M, Meijgaard J, Mehra MR, et al. Prescription fill patterns for commonly used drugs during the COVID-19 pandemic in the United States. JAMA. 2020; https://doi.org/10.1001/jama.2020.9184.</Citation></Reference><Reference><Citation>COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health. https://www.covid19treatmentguidelines.nih.gov/. Accessed May 24, 2019.</Citation></Reference><Reference><Citation>Qaseem A, Yost J, Etxeandia-Ikobaltzeta I, et al. Should clinicians use chloroquine or hydroxychloroquine alone or in combination with azithromycin for the prophylaxis or treatment of COVID-19? Living Practice Points From the American College of Physicians (Version 1) [published online ahead of print 2020]. Ann Intern Med. https://doi.org/10.7326/M20-1998. Accessed June 6, 2020.</Citation></Reference><Reference><Citation>Alhazzani W, Møller MH, Arabi YM, et al. Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19). Crit Care Med. 2020;48(6):e440-3469.</Citation></Reference><Reference><Citation>Bhimraj A, Morgan RL, Shumaker AH, et al. Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19. 2020. https://www.idsociety.org/practice-guideline/covid-19-guideline-treatment-and-management/#toc-1. Accessed June 5, 2020.</Citation></Reference><Reference><Citation>Wilson KC, Chotirmall SH, Bai C, et al. COVID-19: Interim Guidance on Management Pending Empirical Evidence. From an American Thoracic Society-led International Task Force; 2020. https://www.thoracic.org/covid/covid-19-guidance.pdf. Accessed June 5, 2020.</Citation></Reference><Reference><Citation>Hernandez AV, Roman YM, Pasupuleti V, et al. Hydroxychloroquine or chloroquine for treatment or prophylaxis of COVID-19: a living systematic review [published online ahead of print 2020]. Ann Intern Med. https://doi.org/10.7326/M20-2496.</Citation></Reference><Reference><Citation>AAPS. The probabilities of clinical success using hydroxychloroquine with or without azithromycin +/-zinc against the novel betacoronavirus, SARS-CoV-2. https://drive.google.com/file/d/1w6p_HqRXCrW0_wYNK7m_zpQLbBVYcvVU/view. Accessed May 25, 2020.</Citation></Reference><Reference><Citation>Hanua S. Orthodox doctor who promoted coronavirus cocktail is leaving the community where he tested his treatment; 2020. https://www.jta.org/2020/05/20/united-states/orthodox-doctor-who-promoted-coronavirus-cocktail-is-leaving-the-community-where-he-tested-his-treatment. Accessed May 26, 2020.</Citation></Reference><Reference><Citation>McKenna C. Kiryas Joel leaders urge doctor to stop making videos about KJ virus cases. https://www.recordonline.com/news/20200324/kiryas-joel-leaders-urge-doctor-to-stop-making-videos-about-kj-virus-cases. Accessed May 25, 2020.</Citation></Reference><Reference><Citation>Gao J, Tian Z, Yang X. Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. J-Stage. 2020;14:72-73. https://doi.org/10.5582/bst.2020.01047.</Citation></Reference><Reference><Citation>Agency for Healthcare Research and Quality. Methods Guide for Effectiveness and Comparative Effectiveness Reviews. AHRQ publication no. 10(14)-EHC063-EF. Rockville, MD: Agency for Healthcare Research and Quality; 2014. www.effectivehealthcare.ahrq.gov. Accessed May 19, 2020.</Citation></Reference><Reference><Citation>Cochrane Collaborative. Cochrane Handbook for Systematic Reviews of Interventions. https://training.cochrane.org/handbook. Accessed May 26, 2020.</Citation></Reference><Reference><Citation>Boyd CM, Singh S, Varadhan R, et al. Methods for Benefit and Harm Assessment in Systematic Reviews. Methods Research Report. AHRQ Publication No. 12(13)-EHC150-EF. Rockville, MD; 2012.</Citation></Reference><Reference><Citation>Chen J, Ping L, Li L, et al. Preliminary study of hydroxychloroquine sulfate in treating common coronavirus disease (COVID-19) patients in 2019 [published online ahead of print 2020]. J Zhejiang Univ. https://doi.org/10.3785/j.issn.1008-9292.2020.03.03.</Citation></Reference><Reference><Citation>Barbosa J, Kaitis D, Freedman R, Le K, Lin X. Clinical outcomes of hydroxychloroquine in hospitalized patients with COVID-19: a quasi-randomized comparative study. N Engl J Med. Submission ID 20-08882. 4 April 4, 2020.</Citation></Reference><Reference><Citation>Mahévas M, Tran VT, Roumier M, et al. No evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for COVID-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial. medRxiv. 2020. Preprint. https://doi.org/10.1101/2020.04.10.20060699</Citation></Reference><Reference><Citation>Magagnoli J, Narendran S, Pereira F, et al. Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19. medRxiv. 2020. https://doi.org/10.1101/2020.04.16.20065920.</Citation></Reference><Reference><Citation>Yu B, Wang DW, Li C. Hydroxychloroquine application is associated with a decreased mortality in critically ill patients with COVID-19. medRxiv. 2020. https://doi.org/10.1101/2020.04.27.20073379. Accessed June 6, 2020.</Citation></Reference><Reference><Citation>Mallat J, Hamed F, Balkis M, et al. Hydroxychloroquine is associated with slower viral clearance in clinical COVID-19 patients with mild to moderate disease: a retrospective study. medRxiv. 2020 https://doi.org/10.1101/2020.04.27.20082180.</Citation></Reference><Reference><Citation>Membrillo de Novales FJ, Ramírez-Olivencia G, Estébanez M, et al. Early hydroxychloroquine is associated with an increase of survival in COVID-19 patients: an observational study. 2020. https://doi.org/10.20944/preprints202005.0057.v1.</Citation></Reference><Reference><Citation>Geleris J, Sun Y, Platt J, et al. Observational study of hydroxychloroquine in hospitalized patients with Covid-19 [published online ahead of print 2020]. N Engl J Med. https://doi.org/10.1056/NEJMoa2012410. Accessed June 6, 2020.</Citation></Reference><Reference><Citation>RECOVERY Trial Investigators. No clinical benefit from use of hydroxychloroquine in hospitalised patients with COVID-19; 2020. https://www.recoverytrial.net/news/statement-from-the-chief-investigators-of-the-randomised-evaluation-of-covid-19-therapy-recovery-trial-on-hydroxychloroquine-5-june-2020-no-clinical-benefit-from-use-of-hydroxychloroquine-in-hospitalised-patients-with-covid-19. Accessed June 5, 2020.</Citation></Reference><Reference><Citation>Boulware DR, Pullen MF, Bangdiwala AS, et al. A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19 [published online ahead of print 2020]. N Engl J Med. https://doi.org/10.1056/NEJMoa2016638.</Citation></Reference><Reference><Citation>Hydroxychloroquine sulfate tablets, USP prescribing information. Concordia Pharmaceuticals; 2017. https://www.bing.com/search?q=malaria+resistance+for+hydroxychloroquine&form=EDGTCT&qs=PF&cvid=b2e1888582e34231bcff7dd5e8cd7c25&refig=025a4bcf5239463d8518321361c609b3&cc=US&setlang=en-US&elv=AY3%21uAY7tbNNZGZ2yiGNjfNJgZcjC02lg78Y%21CNJGTBOGjXHmBlxaYCFWY4ctSOjWl4yKa9gvd3rADbFF3XTxsCCIIsru82xKGmXxZDoN**2. Accessed May 26, 2020.</Citation></Reference><Reference><Citation>CDC. Drug Resistance in the Malaria-Endemic World. https://www.cdc.gov/malaria/malaria_worldwide/reduction/drug_resistance.html. Accessed May 5, 2020.</Citation></Reference><Reference><Citation>Lupus Foundation. FDA Recognizes Hydroxychloroquine and Chloroquine Shortages; 2020. https://www.lupus.org/news/fda-recognizes-hydroxychloroquine-and-chloroquine-shortages. Accessed May 26, 2020.</Citation></Reference><Reference><Citation>Davis P. U.S. Customs in Baltimore say they've seized thousands of unapproved or counterfeit coronavirus tests, masks and medications. https://www.baltimoresun.com/coronavirus/bs-md-fake-coronavirus-medications-seizures-20200511-ezodjdqqevde5ibkdedsrezn24-story.html. Accessed May 26, 2020.</Citation></Reference><Reference><Citation>Serebrov M. COVID-19 underscores threat of counterfeit antibiotics, antimalarials. BioWorld. https://www.bioworld.com/articles/434586-covid-19-underscores-threat-of-counterfeit-antibiotics-antimalarials. Accessed May 26, 2020.</Citation></Reference><Reference><Citation>White CM. Counterfeit drugs: a major issue for vulnerable citizens throughout the world and in the United States [published online ahead of print 2020]. J Am Pharm Assoc. https://doi.org/10.1016/j.japh.2020.04.020.</Citation></Reference><Reference><Citation>Lapin T. Man dies after self-medicating with chloroquine phosphate to treat coronavirus. NY Post. https://nypost.com/2020/03/23/man-dies-after-self-medicating-with-chloroquine-phosphate-to-treat-coronavirus/. Accessed May 26, 2020.</Citation></Reference><Reference><Citation>AMA, APhA, ASHP. UPDATED Joint Statement of the American Medical Association, American Pharmacists Association, and American Society of Health-System Pharmacists on Inappropriate Ordering, Prescribing or Dispensing of Medications to Treat COVID-19. https://www.ashp.org/-/media/assets/pharmacy-practice/resource-centers/Coronavirus/docs/AMA-APhA-ASHP-statement-ensuring-access-to-medicines-covid19.ashx. Accessed May 26, 2020.</Citation></Reference></ReferenceList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001424 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 001424 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidChloroV1
|flux= Main
|étape= Corpus
|type= RBID
|clé= pubmed:32530493
|texte= Why Your Patients' Believing Hydroxychloroquine and Chloroquine Are 90% Effective for COVID-19 Is 100% Dangerous.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i -Sk "pubmed:32530493" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a CovidChloroV1
| This area was generated with Dilib version V0.6.38. |  |